Research Topics
Genomes and GenesSpecies | D J SugarbakerSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencingLingsheng Dong
The Thoracic Surgery Oncology Laboratory and Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
BMC Med Genet 10:149. 2009..We hypothesized that alternative splicing profiles might be detected in the sequencing data for the expressed genes in these samples...
Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitroGavin J Gordon
Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
BMC Cancer 11:169. 2011..In this study, we determined whether any of these four genes could be linked to a cancer relevant phenotype...
Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesotheliomaDavid J Sugarbaker
Department of Surgery, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
J Thorac Oncol 1:175-6. 2006
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomyDavid J Sugarbaker
Division of Thoracic Surgery and Department of Pathology, Brigham and Women s Hospital, Boston, MA, USA
Eur J Cardiothorac Surg 40:298-303. 2011..We explored factors associated with 3-year survival in patients with malignant pleural mesothelioma, who underwent extrapleural pneumonectomy, to help refine patient selection criteria for surgery and other therapies...
Surgery for malignant pleural mesotheliomaDavid J Sugarbaker
Division of Thoracic Surgery, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Expert Rev Respir Med 4:363-72. 2010..Pending the discovery of new drugs, the focus of clinical research over the next 5 years will emphasize refinements in patient selection, pathologic staging, molecular staging and other novel adjuvant therapies...
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomiesDavid J Sugarbaker
Division of Thoracic Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
J Thorac Cardiovasc Surg 128:138-46. 2004..Complications after extrapleural pneumonectomy were further analyzed to elucidate means of prevention, early detection, and treatment...
Diagnostic workup of lung cancerDavid J Sugarbaker
Division of Thoracic Surgery, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115 6195, USA
Surg Oncol Clin N Am 20:667-79. 2011..The two major histologic types of lung cancer are small cell lung cancer and non-small cell lung cancer. The diagnosis and management of lung cancer requires a multidisciplinary approach...
Lung cancer. 6: The case for limited surgical resection in non-small cell lung cancerD J Sugarbaker
Harvard Medical School, Division of Thoracic Surgery, Brigham and Women s Hospital, Boston, MA, USA
Thorax 58:639-41. 2003..The choice between conservative resection or standard anatomical resection for stage I NSCLC depends on the size and biology of the tumour and the age and state of health of the patient...
Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesotheliomaG J Gordon
The Thoracic Surgery Oncology Laboratory and the Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
J Pathol 211:439-46. 2007....
New surgical options for elderly lung cancer patientsM T Jaklitsch
Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Chest 116:480S-485S. 1999..Age alone should not be a contradiction to thoracic surgical interventions when video thoracoscopy is performed as treatment...
Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinomaS J Swanson
Division of Thoracic Surgery, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Ann Thorac Surg 72:1918-24; discussion 1924-5. 2001..The technique includes right thoracotomy, laparotomy, and cervical esophagogastrostomy (total thoracic esophagectomy) with radical mediastinal and abdominal lymph node dissection...
Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experienceAaron M Allen
Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
Cancer 112:1106-13. 2008..The current study was conducted to examine the outcomes of pneumonectomy after induction chemoradiotherapy in patients with locally advanced nonsmall cell lung cancer (NSCLC)...
Four-gene expression ratio test for survival in patients undergoing surgery for mesotheliomaGavin J Gordon
Department of Surgery, Division of Thoracic Surgery, Harvard Medical School and Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
J Natl Cancer Inst 101:678-86. 2009..In this study, we investigated the predictive value and technical assay performance of this test in patients with malignant pleural mesothelioma...
Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chestM T Jaklitsch
Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
J Thorac Cardiovasc Surg 121:657-67. 2001..CONCLUSIONS: Multiple attempts to re-establish intrathoracic control of metastatic disease is justified in carefully selected patients, but the magnitude of benefit decays with each subsequent attempt...
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implicationsD J Kwiatkowski
Division of Experimental Medicine, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
J Clin Oncol 16:2468-77. 1998..To retrospectively construct a comprehensive multivariate model of cancer recurrence and to design a molecular pathologic substaging system in stage I non-small-cell lung cancer (NSCLC)...
Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary noduleCarlos M Mery
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Chest 125:2175-81. 2004..Metastases from previous cancer account for almost half of SPNs seen among patients in this subgroup. Diagnosis depends on the histology of previous malignancies, smoking history, age, and size of the SPN...
Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesotheliomaSiyamek Neragi-Miandoab
Department of Surgery, Cardiothoracic Surgery, Boston University Medical Center, School of Medicine, One Boston Medical Center Place, Boston MA 02118, USA
Int J Surg 6:293-7. 2008....
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsGary M Strauss
Tufts Medical Center, Division of Medical Oncology, Tufts NEMC, Boston, MA 02111, USA
J Clin Oncol 26:5043-51. 2008..This report provides a mature analysis of Cancer and Leukemia Group B (CALGB) 9633, the only RCT designed specifically for stage IB NSCLC...
Treatment of malignant mesotheliomaM T Jaklitsch
Department of Surgery, Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA
World J Surg 25:210-7. 2001..Innovative therapies such as the use of photodynamic, targeted cytokines and gene therapy are currently being investigated for management of MPM...
AXL regulates mesothelioma proliferation and invasivenessW B Ou
Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Oncogene 30:1643-52. 2011..AXL inhibition suppressed mesothelioma anchorage-independent growth, with reduction in colony numbers and size. These studies suggest that AXL inhibitors warrant clinical evaluation in mesothelioma...
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective studyTamara R Tilleman
Department of Thoracic Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
J Thorac Cardiovasc Surg 138:405-11. 2009..We sought to prospectively determine the feasibility and safety of hyperthermic intraoperative intracavitary cisplatin perfusion immediately after extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma...
Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimensAneil A Mujoomdar
Division of Thoracic Surgery, Department of Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
J Thorac Cardiovasc Surg 140:352-5. 2010..In vitro chemotherapy resistance in human mesothelioma has not been reported. Our goal was to determine the prevalence of drug resistance in a large sample of malignant pleural mesothelioma using a commercially available assay...
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesotheliomaAaron M Allen
Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA, USA
Int J Radiat Oncol Biol Phys 65:640-5. 2006..To describe the initial experience at Dana-Farber Cancer Institute/Brigham and Women's Hospital with intensity-modulated radiation therapy (IMRT) as adjuvant therapy after extrapleural pneumonectomy (EPP) and adjuvant chemotherapy...
Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomyAaron M Allen
Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 68:1366-74. 2007..We compared the outcomes after moderate-dose hemithoracic radiotherapy (MDRT) and high-dose hemithoracic RT (HDRT) after EPP for malignant pleural mesothelioma...
Surveillance transbronchial lung biopsies: implication for survival after lung transplantationS J Swanson
Lung Transplant Program, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
J Thorac Cardiovasc Surg 119:27-37. 2000..We wished to determine whether early rejection after lung transplantation as assessed by surveillance transbronchial biopsy predicts for survival...
Current trends in radiologic management of malignant pleural mesotheliomaRitu R Gill
Department of Radiology, Division of Thoracic Surgery, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Semin Thorac Cardiovasc Surg 21:111-20. 2009..This review focuses on the practical aspects of the radiological assessment of MPM, highlighting the role of the radiologist in preoperative and postoperative evaluation with a multimodality approach...
Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decorticationAndrea S Wolf
Division of Thoracic Surgery, Brigham and Women s Hospital, Boston, Massachusettes 02115, USA
Semin Thorac Cardiovasc Surg 21:132-48. 2009..Both operations are technically complex and should only be performed at experienced high-volume centers...
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesotheliomaGavin J Gordon
Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Carcinogenesis 23:1017-24. 2002..Our observations strongly suggest that IAP-1 is at least partly responsible for promoting carcinogenesis and mediating resistance to cisplatin in many MPM tumors and that further study of this apoptotic pathway is warranted...
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgeryHale B Caglar
Department of Radiation Oncology Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, Massachusetts 02215, USA
Cancer 115:4156-66. 2009..The objective of this study was to identify the factors associated with improved outcome after treatment for stage III nonsmall cell lung cancer (NSCLC)...
Using gene expression ratios to predict outcome among patients with mesotheliomaGavin J Gordon
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
J Natl Cancer Inst 95:598-605. 2003..This technique could impact the clinical treatment of mesothelioma by allowing the preoperative identification of patients with widely divergent prognoses...
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesotheliomaLambros Zellos
Division of Thoracic Surgery and Department of Pathology, Brigham and Women s Hospital, Boston, Mass, USA
J Thorac Cardiovasc Surg 137:453-8. 2009..This study was undertaken to determine maximum tolerated dose and toxicity of intraoperative intracavitary hyperthermic cisplatin perfusion with amifostine after extrapleural pneumonectomy for malignant pleural mesothelioma...
Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesotheliomaG J Gordon
The Thoracic Surgery Oncology Laboratory and the Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
J Pathol 211:447-54. 2007..Only IAP-1 and livin protein was expressed in the nucleus of MPM tumours. These results provide the rationale for additional study of this gene family in MPM and cancer in general...
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I diseaseO S Breathnach
Lowe Center for Thoracic Oncology, Division of Experimental Medicine, Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Thorac Cardiovasc Surg 121:42-7. 2001..Further research is warranted to define the etiology, clinical course, and molecular abnormalities in patients with bronchioloalveolar carcinoma to generate more effective therapeutic approaches...
Lung cancer staging and treatment in multidisciplinary trials: Cancer and Leukemia Group B cooperative group approach. Thoracic Surgeons of CALGBM J Krasna
Division of Thoracic Surgery, University of Maryland Medical School, Baltimore 21201, USA
Ann Thorac Surg 68:201-7. 1999..Less than 1% of lung cancer patients in the United States are currently being treated in a clinical trial. Only with results from large, prospective trials can the questions of neoadjuvant and adjuvant therapy be answered...
CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancerM J Krasna
Division of Thoracic Surgery, University of Maryland Medical System, Baltimore 21201, USA
Ann Thorac Surg 71:1073-9. 2001..We report the experience of an Intergroup NCI trial (CALGB 9380) evaluating the feasibility and accuracy of this staging modality...
Hyperthermic chemoperfusion for the treatment of malignant pleural mesotheliomaAneil A Mujoomdar
Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Semin Thorac Cardiovasc Surg 20:298-304. 2008..Further trials are being performed with a multidrug combination following macroscopic complete resection...
Diffuse malignant mesothelioma of the pleural space and its managementLambros S Zellos
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Oncology (Williston Park) 16:907-13; discussion 916-7, 919-20, 925. 2002..However, innovative therapies are still needed to prolong survival in patients with early and advanced disease...
A prognostic test for adenocarcinoma of the lung from gene expression profiling dataGavin J Gordon
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Cancer Epidemiol Biomarkers Prev 12:905-10. 2003..Our results provide additional evidence that expression ratios are highly accurate in predicting cancer recurrence and may be used in a simple test to predict response to surgical therapy in early-stage lung adenocarcinoma...
Primary Ewing sarcoma invading the heart: resection and reconstructionSubroto Paul
Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass 02115, USA
J Thorac Cardiovasc Surg 133:1667-9. 2007
Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesotheliomaSiyamek Neragi-Miandoab
Department of Surgery, St Vincent Medical Center, New York Medical College, School of Medicine, New York, NY 10011, USA
Interact Cardiovasc Thorac Surg 7:1039-42. 2008..We conclude that EPP vs. pleurectomy and age over 65 years are risk factors for postoperative AF. The increased odds of having AF after EPP could be due to right heart stress caused by pneumonectomy...
Malignant pleural mesothelioma: overview of the North American and European experienceJasleen Kukreja
Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
Thorac Surg Clin 14:435-45. 2004....
Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935Michael T Jaklitsch
Division of Thoracic Surgery, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
J Surg Oncol 94:599-606. 2006..Induction cisplatin/vinblastine chemotherapy was followed by surgical resection, adjuvant cisplatin/vinblastine, and radiotherapy. We now evaluate the prognosis of pathologic nodes...
Characteristics of malignant pleural mesothelioma in womenAndrea S Wolf
Division of Thoracic Surgery, Brigham and Women s Hospital, Boston, Massachusetts 02215, USA
Ann Thorac Surg 90:949-56; discussion 956. 2010..Women also appear to experience better long-term survival. This study evaluates the role of gender in relation to established prognostic factors in MPM...
Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesotheliomaGavin J Gordon
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Cancer Res 62:4963-7. 2002..Furthermore, we provide evidence suggesting that this technique can be equally accurate in other clinical scenarios...
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomyJohn G Byrne
Cardiac Surgery, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
Chest 122:2256-9. 2002..When patients present with dyspnea, hepatojugular reflux, and peripheral edema refractory to diuretics, constrictive cardiac physiology should be considered in the differential diagnosis, even in the absence of parietal pericardium...
Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement ProgramPhilip A Linden
Division of Thoracic Surgery, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Ann Thorac Surg 83:425-31; discussion 432. 2007..The risks of repeat lung resection have not been well quantified or analyzed. We used a national, prospectively recorded database to evaluate the complication rate and risk factors in this population...
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesotheliomaRaphael Bueno
Division of Thoracic Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
Ann Thorac Surg 78:1774-6. 2004..Pleural biopsy has been proposed as the diagnostic gold standard. We investigated the accuracy of open pleural biopsy for diagnosis and subtype identification in MPM...
Modified T-tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforationsPhilip A Linden
Division of Thoracic Surgery, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Ann Thorac Surg 83:1129-33. 2007..We present a large series of patients requiring operative treatment of esophageal perforations with attention to an infrequently used method of dealing with delayed intrathoracic perforations...
Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesotheliomaBrock C Christensen
Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA
Carcinogenesis 29:1555-9. 2008..These data suggest a novel tumorigenic mechanism of action of asbestos and may contribute to the understanding of precisely how asbestos exposure influences the etiology and clinical course of malignant mesothelioma...
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesotheliomaGavin J Gordon
The Thoracic Surgery Oncology Laboratory and the Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA
Cancer Chemother Pharmacol 61:549-58. 2008..Bortezomib may improve outcome in MPM patients alone or in combination with standard chemotherapy but the order of administration is likely to be important. This study justifies further evaluation of bortezomib in MPM...
Current surgical management of malignant pleural mesotheliomaLambros Zellos
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Curr Oncol Rep 4:354-60. 2002..The lack of cure in any of the published protocols demonstrates the need for new therapies and approaches for this disease...
Transcriptome sequencing of malignant pleural mesothelioma tumorsDavid J Sugarbaker
International Mesothelioma Program, Division of Thoracic Surgery, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 105:3521-6. 2008..Of the seven point mutations, three were observed in at least one tumor from 49 other MPM patients. The mutations were in genes that could be causally related to cancer and included XRCC6, PDZK1IP1, ACTR1A, and AVEN...
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancerJussi P Koivunen
Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, D820A, 44 Binney Street, Boston, MA 02115, USA
Clin Cancer Res 14:4275-83. 2008..We determined the frequency of EML4-ALK in Caucasian NSCLC and in NSCLC cell lines. We also determined whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK-containing cell lines in vitro and in vivo...
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I studyLori J Wirth
Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA
Clin Cancer Res 9:1698-704. 2003..DOC at 30 mg/m(2) in combination with CAR and RT is recommended for Phase II study...
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypesRitu R Gill
Department of Radiology, Brigham and Women s Hospital, Boston, MA 02115, USA
AJR Am J Roentgenol 195:W125-30. 2010....
Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoringAndrea S Wolf
Division of Thoracic Surgery and Department of Radiology, Brigham and Women s Hospital, Boston, MA 02215, USA
Eur J Cardiothorac Surg 37:770-5. 2010..In this retrospective analysis, we evaluate the efficacy of intrathoracic pressure monitoring and intermittent fluid aspiration to manage the pneumonectomy space in the early postoperative period following extrapleural pneumonectomy...
Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1Nishit K Mukhopadhyay
Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Ann Thorac Surg 78:450-7. 2004..During invasion, tumor cells attach to the basement membrane protein, collagen type IV, degrade it, migrate through blood vessels, and adhere to extracellular matrix proteins...
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantationPhilip A Linden
Division of Thoracic Surgery, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02115, USA
J Thorac Cardiovasc Surg 131:438-46. 2006..We evaluated the risk and physiologic effect of laparoscopic fundoplication in patients on the lung transplant waiting list...
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiationHarvey J Mamon
Department of Radiation Oncology and Medical Oncology, Dana-Farber/Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA
J Clin Oncol 23:1530-7. 2005..Because brain metastases constitute the most common site of failure in these patients, future studies focusing on prophylaxis of brain metastases may improve the outcome in patients with stage IIIA NSCLC...
The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experienceJohn G Byrne
The Division of Cardiac Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
Chest 125:1581-6. 2004..The availability of CPB also provides a safety net in the event of injury to vascular structures during tumor resection...
Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 casesWilliam G Richards
Division of Thoracic Surgery, Brigham and Women s Hospital, Thoracic Surgery, 75 Francis Street, Boston, MA 02115, USA
Cancer 116:1510-7. 2010..Interpretation of prior studies that correlate pathologic factors with outcome has been confounded by the inclusion of patients undergoing differing surgical procedures and with varied tumor histology...
Lung resection in patients with preoperative FEV1 < 35% predictedPhilip A Linden
Division of Thoracic Surgery, Brigham and Women s Hospital and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
Chest 127:1984-90. 2005..To determine the morbidity, mortality, and feasibility of lung resection in patients with tumors and preoperative FEV1 < 35% predicted...
Validation of genomics-based prognostic tests in malignant pleural mesotheliomaGavin J Gordon
Thoracic Surgery Oncology Laboratory and Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Clin Cancer Res 11:4406-14. 2005..In this report, we examine the accuracy of a previously proposed prognostic test in an independent cohort of MPM patients. This test uses simple ratios of gene expression levels to provide a novel prognostication scheme...
Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results databaseCarlos M Mery
Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
Chest 128:237-45. 2005..Among younger patients undergoing curative surgery, lobectomies are more commonly performed and confer a significant survival benefit over limited resections. This benefit, however, is not evident for patients > 71 years of age...
Percutaneous treatment of high-output chylothorax with embolization or needle disruption techniqueChristoph A Binkert
Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115, USA
J Vasc Interv Radiol 16:1257-62. 2005..The median times to chest tube removal were 7 days in the embolization group and 3.5 days in the needle disruption group...
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profilingGavin J Gordon
Thoracic Surgery Oncology Laboratory, Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Am J Pathol 166:1827-40. 2005..Finally, we used bioinformatics tools (ie, software) to create and explore complex physiological pathways. Combined, all of these data may advance our understanding of mesothelioma tumorigenesis, pathobiology, or both...
Surgery for early stage non-small cell lung cancerMichael Y Chang
Harvard Medical School and Division of Thoracic Surgery, Brigham and Women s Hospital 75 Francis Street Boston, MA 02115, USA
Semin Surg Oncol 21:74-84. 2003..Methods that identify early-stage lung cancer patients at greatest risk for recurrence are needed to identify patients who may benefit from additional therapies...
Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancerNishit K Mukhopadhyay
Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Ann Thorac Surg 81:1034-42. 2006....
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesotheliomaWilliam G Richards
Brigham and Women's Hospital, Boston, MA 02115, USA
J Clin Oncol 24:1561-7. 2006..CONCLUSION: Pleurectomy and high-dose intraoperative intracavitary hyperthermic cisplatin lavage is feasible in this patient population with restricted surgical options. An apparent dose-related survival benefit warrants further study...
Insulin receptor activation in solitary fibrous tumoursY Li
Department of Pathology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
J Pathol 211:550-4. 2007..The aetiological relevance of IGF-2 is supported by expression of IR-A, the IR isoform with high affinity for IGF-2, in all SFTs. Our studies suggest that IR activation plays an oncogenic role in SFTs...
Health-related quality of life after elective surgery: measurement of longitudinal changesC M Mangione
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass, USA
J Gen Intern Med 12:686-97. 1997....
Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstructionR Bueno
Division of Thoracic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Gastrointest Endosc 54:368-72. 2001..All strictures were dilated and no perforations occurred. CONCLUSIONS: Combined antegrade and retrograde dilation is a safe and effective technique for dilation of complex obstructing esophageal lesions...
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor typesIan Krop
Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, D740C, Boston, MA 02115, USA
Mol Cancer Res 2:489-94. 2004..Thus, silencing of HIN-1 expression and methylation of its promoter occurs in multiple human cancer types, suggesting that elimination of HIN-1 function may contribute to several forms of epithelial tumorigenesis...
Multimodality treatment of diffuse malignant pleural mesotheliomaLambros S Zellos
Department of Surgery, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA
Semin Oncol 29:41-50. 2002..Randomized controlled studies comparing various strategies are lacking and, thus, the debate continues regarding the effectiveness of different treatment approaches...
Asbestos burden predicts survival in pleural mesotheliomaBrock C Christensen
Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA
Environ Health Perspect 116:723-6. 2008..Malignant pleural mesothelioma (MPM) is a rapidly fatal asbestos-associated malignancy with a median survival time of <1 year following diagnosis. Treatment strategy is determined in part using known prognostic factors...
Innovative therapies: intraoperative intracavitary chemotherapyMichael Y Chang
Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
Thorac Surg Clin 14:549-56. 2004..By approaching the problem of local recurrence after resection of MPM in a careful and methodical manner, we hope to decrease or delay the rate of recurrence and potentially improve longterm survival in patients with this lethal disease...
Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathologyVictor H Gerbaudo
Division of Nuclear Medicine, Department of Radiology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
J Nucl Med 43:1144-9. 2002..The purpose of this study was to evaluate the usefulness of (18)F-FDG-CI in the assessment of malignant pleural mesothelioma using histopathology as the gold standard...
Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complicationsMichael Y Chang
Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
Thorac Surg Clin 14:523-30. 2004..Although mesothelioma remains a difficult disease to treat, the techniques of surgical resection for mesothelioma have improved dramatically. Currently, EPP can be performed with acceptable morbidity and mortality at experienced centers...
Factors predicting poor survival after resection of stage IA non-small cell lung cancerMichael Y Chang
Division of Thoracic Surgery, Brigham and Women s Hospital, Harvard Medical School, and Boston VA Healthcare, Harvard School of Public Health, Boston, Mass, USA
J Thorac Cardiovasc Surg 134:850-6. 2007..Using a national cancer registry, we determined the postoperative survival of patients with stage IA non-small cell lung cancer in the United States from 1988 to 1997 and identified factors that affect survival...
Morphologic and functional imaging of malignant pleural mesotheliomaMasaki Yamamuro
Department of Radiology and Surgery, Brigham and Women s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Eur J Radiol 64:356-66. 2007..PET/CT seems to be superior to other imaging modalities in detecting more extensive disease involvement, and identifying unsuspected occult distant metastases...
Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancerKimberly A Moore
Division of Thoracic Surgery, Department of General Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Ann Thorac Surg 76:1789-95. 2003..Results suggest that estrogen exposure creates a milieu that may confer a protective effect through some yet unknown mechanisms that determine outcome of the neoplastic process and warrant further investigation...
Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblastN K Mukhopadhyay
Division of Thoracic Surgery, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
J Cell Mol Med 9:662-9. 2005..Collectively, our study indicates that inhibition of histone deacetylation selectively regulates the transcriptional derepression of telomerase catalytic subunit in normal lung fibroblast cells compared to lung tumor cells...
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patientsJ P Koivunen
Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Br J Cancer 99:245-52. 2008..002). The outcome of stages I and II NSCLC patients treated with surgery alone did not significantly differ based on LKB1 mutation status. Our study provides clinical and molecular characteristics of NSCLC, which harbour LKB1 mutations...
Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesotheliomaV H Gerbaudo
Division of Nuclear Medicine, Department of Radiology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Thorax 58:1077-82. 2003..This pilot study evaluated the significance of the pattern, intensity and kinetics of 18F-FDG uptake in mesothelioma in the context of histopathology and surgical staging...
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclassesA Bhattacharjee
Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 98:13790-5. 2001..These results suggest that integration of expression profile data with clinical parameters could aid in diagnosis of lung cancer patients...
Unusual case of hemoptysis 13 years after bilobectomySubroto Paul
Division of Thoracic Surgery, Department of Surgery, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Ann Thorac Surg 83:1188-90. 2007..Successful treatment required percutaneous embolization of the dominant bronchial collaterals, followed by completion pneumonectomy...
Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility studyScott J Swanson
Surgery Committee of the Cancer and Leukemia Group B CALGB, Statistics Office of CALGB, and Respiratory Committee of CALGB, Chicago, IL, USA
J Clin Oncol 25:4993-7. 2007..To evaluate the technical feasibility and safety of video-assisted thoracic surgery (VATS) lobectomy for small lung cancers...
Cardiac sarcoma 14 years after treatment for pleural mesotheliomaSiyamek Neragi-Miandoab
N Engl J Med 352:1929-30. 2005
Non-small cell lung cancerDavid S Ettinger
J Natl Compr Canc Netw 6:228-69. 2008
Complications of extrapleural pneumonectomyLambros Zellos
Department of Thoracic Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
Semin Thorac Cardiovasc Surg 19:355-9. 2007..We have drawn upon our single-institution experience to describe the most common source of morbidity following EPP and to offer successful interventions...
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumorsCarmen J Marsit
Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA
Cancer Res 66:10621-9. 2006....
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesotheliomaRamasamy Jagadeeswaran
Section of Hematology/Oncology, Department of Medicine, University of Chicago Cancer Research Center, University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois 60637, USA
Cancer Res 66:352-61. 2006..Ultimately, c-Met would be an important target for therapy against MPM...
Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stageCarlos M Mery
Division of Thoracic Surgery and Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Chest 128:3255-60. 2005..0 to 4.9 cm and 5.0 to 6.0 cm. CONCLUSIONS: The T descriptor should be changed so that T1 is reserved for tumors < 2 cm. Further refinement of larger tumors into T2a (2 to 3.9 cm) and T2b (> or = 4 cm) should be considered...
Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling eventsNishit K Mukhopadhyay
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115, USA
J Cell Mol Med 9:387-97. 2005..Collectively, this report defines the existence of multiple and potentially parallel Coll IV/beta1-integrin mediated signaling events in Calu-1 cells, which involve FAK, ERKs, and PKC...
mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroidsShannon M Wilson
Lung Biology Center, UCSF, San Francisco, CA 94143 0854, USA
Am J Respir Cell Mol Biol 39:576-83. 2008..We propose that mTOR mediates survival signals in many mesothelioma tumors. Inhibition of mTOR may provide a nontoxic adjunct to therapy directed against malignant mesothelioma, especially in those with high baseline expression of p-S6K...
Non-small cell lung cancer clinical practice guidelines in oncologyDavid S Ettinger
J Natl Compr Canc Netw 4:548-82. 2006
Esophageal cancer. IntroductionDavid J Sugarbaker
Harvard Medical School, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA
Semin Thorac Cardiovasc Surg 15:157. 2003
Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?Hiromichi Ito
Department of Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Am Coll Surg 199:880-6. 2004..The incidence of adenocarcinoma of the gastric cardia is rising in Western countries. This study evaluates prognostic factors associated with surgical management of this cancer...
Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell linesGavin J Gordon
Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA
Oncol Rep 9:631-4. 2002..In addition, SV40 sequences were found in 2/35 tissues and 3/7 cell lines in relatively low abundance. We conclude that SV40 is not a contributing factor in the pathobiology of the majority of MPM tumors from patients at our institution...
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemiaMohamed Bentires-Alj
Cancer Biology Program, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Cancer Res 64:8816-20. 2004..Our data demonstrate that mutations in PTPN11 occur at low frequency in several human cancers, especially neuroblastoma and AML, and suggest that Shp2 may be a novel target for antineoplastic therapy...
Research Grants
- CANCER AND LEUKEMIA GROUP BDavid Sugarbaker; Fiscal Year: 2002..Three stages of group development are described: (1) surgeon recruitment phase; (2) patient recruitment phase (educational activities about adjuvant therapy trials. etc.); and (3) protocol development phase (intellectual activities). ..
